CCR5 and HIV infectious disease: It has been shown that natural CCR5-specific Abs, found in HIV infection in human [51] or experimentally elicited in animal models [52,53], can induce a long-term downregulation of CCR5 surface expression, resulting in a ‘Δ32-like’ phenotype that can confer resistance to HIV infection [54].